BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 11391835)

  • 1. Renal cell carcinoma in Enugu, Nigeria.
    Aghaji AE; Odoemene CA
    West Afr J Med; 2000; 19(4):254-8. PubMed ID: 11391835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal cell carcinoma in Ibadan: a 5-year clinicopathologic review.
    Takure AO; Shittu OB; Adebayo SA; Okolo CA; Sotunmbi PT
    Afr J Med Med Sci; 2013 Sep; 42(3):239-43. PubMed ID: 24579385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Renal cell adenocarcinomas. Report of 64 cases].
    Trifa M; Langar W; Hadj Slimane M; Jmel S; Bahloul A; Mhiri MN
    Ann Urol (Paris); 1997; 31(3):117-22. PubMed ID: 9273841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Malignant renal tumors in adults: a ten-year review in a Nigerian hospital.
    Badmus TA; Salako AA; Arogundade FA; Sanusi AA; Adesunkanmi AR; Oyebamiji EO; Bakare TI; Oseni GO
    Saudi J Kidney Dis Transpl; 2008 Jan; 19(1):120-6. PubMed ID: 18087141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clear cell renal carcinoma in children. Study of two cases and review of the literature].
    Walter P; Vetter JM
    Ann Pediatr (Paris); 1976 Sep; 23(8-9):541-50. PubMed ID: 16104190
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical presentation and management of renal cell carcinoma.
    Oliech JS
    East Afr Med J; 1998 Oct; 75(10):594-7. PubMed ID: 10065195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Paraneoplastic syndromes in three patients with renal cell carcinoma].
    Steffens MG; de Mulder PH; Mulders PF
    Ned Tijdschr Geneeskd; 2004 Mar; 148(10):487-92. PubMed ID: 15042897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. De novo renal cell carcinoma of native kidney in renal transplant recipients.
    Neuzillet Y; Lay F; Luccioni A; Daniel L; Berland Y; Coulange C; Lechevallier E
    Cancer; 2005 Jan; 103(2):251-7. PubMed ID: 15593084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term outcome of postoperative interferon-alpha adjuvant therapy for non-metastatic renal cell carcinoma.
    Gotoh A; Shirakawa T; Hinata N; Wada Y; Hara I; Fujisawa M; Kawabata G; Okada H; Arakawa S; Kamidono S
    Int J Urol; 2004 May; 11(5):257-63. PubMed ID: 15147539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multi-modal treatment of primarily using continuous subcutaneous interferon-alpha injection in combination with surgery and/or radiotherapy.
    Maruoka M; Fujimura M; Kawamura K; Suzuki S; Hamano M; Nishikawa Y; Nagayama T
    Int J Urol; 2005 May; 12(5):442-8. PubMed ID: 15948742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The severity, outcome and challenges of breast cancer in Nigeria.
    Adesunkanmi AR; Lawal OO; Adelusola KA; Durosimi MA
    Breast; 2006 Jun; 15(3):399-409. PubMed ID: 16085418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal cell carcinoma in dialysis patients: a single center experience.
    Kojima Y; Takahara S; Miyake O; Nonomura N; Morimoto A; Mori H
    Int J Urol; 2006 Aug; 13(8):1045-8. PubMed ID: 16903927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Adult renal cancer in Senegal: Current epidemiological, clinical features, profile's evolution over the two past decades].
    Fall B; Diao B; Sow Y; Sarr A; Thiam A; Fall PA; Ndoye AK; Sylla C; Ba M; Mendes V; Diagne BA
    Prog Urol; 2011 Sep; 21(8):521-6. PubMed ID: 21872154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carcinoma of the gallbladder at the Nnamdi Azikiwe University Teaching Hospital--a 5-year retrospective study.
    Chianakwana GU; Okafor PI; Anyanwu SN
    Niger J Clin Pract; 2005 Jun; 8(1):10-3. PubMed ID: 16392449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Childhood nephrotic syndrome in Enugu, Nigeria.
    Okoro BA; Okafor HU; Nnoli LU
    West Afr J Med; 2000; 19(2):137-41. PubMed ID: 11070750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal cell carcinoma in young adults: incidence, disease outcome and review of the literature.
    Rodríguez A; Patard JJ; Lobel B
    Arch Esp Urol; 2002 Oct; 55(8):969-75. PubMed ID: 12455292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Managing the complex journey of renal cell carcinoma.
    Amen K
    ONS Connect; 2007; 22(8 Suppl):53-4. PubMed ID: 17824565
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical outcome of combined immunotherapy with interferon-alpha and low-dose interleukine-2 for Japanese patients with metastatic renal cell carcinoma.
    Miyake H; Kurahashi T; Takenaka A; Inoue TA; Fujisawa M
    Urol Oncol; 2009; 27(6):598-603. PubMed ID: 18818106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of adjuvant interferon-alpha therapy following curative resection in renal cell carcinoma: before the molecular targeting therapy era.
    Kai F; Takayama T; Sugiyama T; Furuse H; Mugiya S; Ozono S
    Jpn J Clin Oncol; 2009 May; 39(5):310-4. PubMed ID: 19363055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Malignant kidney tumors in adults in Senegal: diagnostic and therapeutic problems].
    Gueye SM; Diallo B; Fall PA; Ndoye AK; Konan PG; Abdallahi MO; Bâ M; Diagne BA
    Dakar Med; 1998; 43(2):213-5. PubMed ID: 10797966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.